Pertuzumab for the treatment of HER2-positive breast cancer: a rapid health technology assessment
JI Wenjun , SHANG Yangjie , MEN Peng , WU Hui , MA Ying
Pertuzumab for the treatment of HER2-positive breast cancer: a rapid health technology assessment
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |